Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Santhera licenses Leber’s hereditary optic neuropathy drug to Chiesi

pharmaceutical-technologyAugust 06, 2019

Tag: Santhera , Hereditary , optic neuropathy drug

PharmaSources Customer Service